Search

Your search keyword '"Kokkali, Stefania"' showing total 39 results

Search Constraints

Start Over You searched for: Author "Kokkali, Stefania" Remove constraint Author: "Kokkali, Stefania" Publication Year Range Last 50 years Remove constraint Publication Year Range: Last 50 years
39 results on '"Kokkali, Stefania"'

Search Results

4. What Is the Prognostic Value of the Pathologic Response after Neoadjuvant Radiotherapy in Soft Tissue Sarcoma? An Institutional Study Using the EORTC–STBSG Response Score.

5. The Impact of Expert Pathology Review and Molecular Diagnostics on the Management of Sarcoma Patients: A Prospective Study of the Hellenic Group of Sarcomas and Rare Cancers.

12. Serum Concentration of Selected Angiogenesis-Related Molecules Differs among Molecular Subtypes, Body Mass Index and Menopausal Status in Breast Cancer Patients

14. A Multicenter, Prospective, Observational Study to Assess the Clinical Activity and Impact on Symptom Burden and Patients’ Quality of Life in Patients with Advanced Soft Tissue Sarcomas Treated with Trabectedin in a Real-World Setting in Greece

16. Front-Line Bevacizumab plus Chemotherapy with or without Maintenance Therapy for Metastatic Breast Cancer: An Observational Study by the Hellenic Oncology Research Group

27. Primary Sarcoma of the Lung – Prognostic Value of Clinicopathological Characteristics of 26 Cases

28. Invasive Lobular Carcinoma with Extracellular Mucin Production: Description of a Case and Review of the Literature

29. Kidney Carcinoma Ovarian Metastasis: Review of the Literature

33. Subcutaneous Trastuzumab Combined with Pertuzumab and Docetaxel as First-line Treatment of Advanced HER2-positive Breast Cancer

35. Gastrointestinal Metastases From Lobular Breast Carcinoma: A Literature Review.

36. A Real-world Study of Everolimus Plus Aromatase Inhibitor in Hormone Receptor-positive, HER2-negative Advanced Breast Cancer.

37. Primary squamous cell carcinoma of the ovary. Review of the literature.

38. Primary peripheral neuroectodermal tumor (PNET) of the adrenal gland: a rare entity.

39. Biweekly Gemcitabine/Nab-Paclitaxel as First-line Treatment for Advanced Pancreatic Cancer.

Catalog

Books, media, physical & digital resources